Trial Details

NULL
Basic Information
Clinical ID c5440
Identifier ACTRN12622000579796
Trial Title A single dose, randomised, 2-period, 2-sequence, crossover, relative bioavailability study comparing 2 x 10 mg R-178 tablets with 2 x 10 mg 2-amino-1,7-dihydro-6H-purine-6-thione tablets administered orally in healthy participants under fasting conditio
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions 2-amino-1,7-dihydro-6H-purine-6-thione is indicated for the maintenance treatment of inflammatory bowel disease (Crohn's disease or ulcerative colitis).; 2-amino-1,7-dihydro-6H-purine-6-thione is indicated for the maintenance treatment of inflammatory
Interventions Single dose, crossover study design whereby each participant receives the test formulation of 2 x 10 mg R-178 tablets on one occasion and the reference formulation 2 x 10 mg 2-amino-1,7-dihydro-6H-purine-6-thione tablets on one occasion with each dose se
Participant Information
Sponsor Zenith Technology Corporation Limited
City NULL
Country/Region New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL